Seilern Investment Management Ltd Reduces Stock Position in CME Group Inc. $CME

Seilern Investment Management Ltd lessened its stake in shares of CME Group Inc. (NASDAQ:CME) by 7.5% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 27,310 shares of the financial services provider’s stock after selling 2,214 shares during the quarter. CME Group comprises about 0.5% of Seilern Investment Management Ltd’s investment portfolio, making the stock its 21st biggest holding. Seilern Investment Management Ltd’s holdings in CME Group were worth $7,527,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently made changes to their positions in the stock. Great Lakes Advisors LLC boosted its holdings in shares of CME Group by 2.3% during the 1st quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider’s stock valued at $441,000 after acquiring an additional 37 shares during the last quarter. SeaCrest Wealth Management LLC boosted its holdings in shares of CME Group by 3.0% during the 1st quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider’s stock valued at $366,000 after acquiring an additional 40 shares during the last quarter. OneAscent Financial Services LLC boosted its holdings in shares of CME Group by 4.0% in the first quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider’s stock worth $293,000 after buying an additional 43 shares during the last quarter. Ballentine Partners LLC boosted its holdings in shares of CME Group by 0.8% in the first quarter. Ballentine Partners LLC now owns 5,828 shares of the financial services provider’s stock worth $1,546,000 after buying an additional 45 shares during the last quarter. Finally, Wealthcare Advisory Partners LLC boosted its holdings in shares of CME Group by 3.6% in the first quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider’s stock worth $356,000 after buying an additional 47 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Trading Down 0.0%

NASDAQ CME opened at $262.30 on Friday. The company’s 50-day moving average price is $273.60 and its 200-day moving average price is $270.45. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a market cap of $94.53 billion, a PE ratio of 25.39, a PEG ratio of 4.75 and a beta of 0.43. CME Group Inc. has a 12 month low of $212.38 and a 12 month high of $290.79.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company had revenue of $1.69 billion for the quarter, compared to analysts’ expectations of $1.68 billion. During the same period in the prior year, the business earned $2.56 EPS. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. Equities research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be given a dividend of $1.25 per share. The ex-dividend date of this dividend is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. CME Group’s dividend payout ratio (DPR) is currently 48.40%.

Wall Street Analyst Weigh In

CME has been the topic of a number of research reports. Oppenheimer raised their price objective on shares of CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a report on Thursday, July 24th. Piper Sandler upped their price target on CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 15th. Erste Group Bank downgraded CME Group from a “strong-buy” rating to a “hold” rating in a research note on Saturday, May 24th. UBS Group decreased their price objective on CME Group from $305.00 to $285.00 and set a “neutral” rating on the stock in a research note on Monday, September 8th. Finally, Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a report on Sunday, July 13th. Four analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, CME Group presently has an average rating of “Hold” and an average price target of $260.60.

Insider Buying and Selling

In other CME Group news, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the transaction, the insider directly owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director William R. Shepard acquired 256 shares of the company’s stock in a transaction dated Wednesday, June 25th. The shares were purchased at an average cost of $270.53 per share, for a total transaction of $69,255.68. Following the purchase, the director directly owned 258,196 shares in the company, valued at approximately $69,849,763.88. This trade represents a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 0.30% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.